ePrints

Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study

Lookup NU author(s): Dr Nicholas Peake, Dr Andrea Myers, Debra Jones, Emeritus Professor Tim Cawston, Emeritus Professor Drew Rowan, Emerita Professor Helen Foster

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Objectives. To measure levels of the collagenases matrix metalloproteinase (MMP)-1 and -13 in the synovial fluid (SF) and serum of patients with juvenile idiopathic arthritis (JIA), and to correlate these measurements with inflammatory activity, levels of the collagenase activator MMP-3 and the tissue inhibitor of metalloproteinases-1 (TIMP-1). Methods. Levels of MMP-1, -3, -13 and TIMP-1 were measured in paired SF and serum from 82 JIA patients using enzyme-linked immunsorbent assay and compared between subtypes and patients of different ages and disease durations. These levels were also correlated to the active joint count (AJC) and standard measures of inflammatory activity and therapeutic response, including erythrocyte sedimentation rate (ESR) and platelet count (PLT). Results. MMP-1 was detected in JIA SF and correlated with PLT. MMP-3 levels were high in SF and detectable in serum where they correlated with PLT, ESR and AJC. MMP-13, however, was not detected in SF or serum. No differences were observed between patients grouped by subtype, age or disease duration. MMP-3 contributed the majority of total MMP in SF samples resulting in excess MMP levels over TIMP-1. Conclusions. MMP-1 is up-regulated in SF concordant with inflammatory activity in JIA. This was true for patients in all JIA subtypes and age groups, suggesting that the capability for degradation of type II collagen is present in early disease, and throughout the disease course. MMP-3 may be important in the activation of collagenases and the saturation of exogenous inhibitors. Serum MMP-3 may therefore be a useful, measurable and specific marker of active disease in JIA.

Publication metadata

Author(s): Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, Foster HE

Publication type: Article

Publication status: Published

Journal: Rheumatology

Year: 2005

Volume: 44

Issue: 11

Pages: 1383-1389

ISSN (print): 0080-2727

ISSN (electronic): 1662-3959

Publisher: S. Karger AG

URL: http://dx.doi.org/10.1093/rheumatology/kei025

DOI: 10.1093/rheumatology/kei025

Altmetrics

Share